Searched for
OPTIMUS PHARMA
Cipla to conduct study on PaxlovidIn its meeting held this week, the SEC granted approval to the company to conduct bioavailability and bio equivalence (BA/BE) studies. “Cip...24 Feb, 2022, 07.24 PM IST- Nod for Paxlovid's Indian generic version to take longerHetero Labs and Optimus Pharma had approached the drug regulatory authority last month seeking waivers from conducting local trials. Howeve...19 Feb, 2022, 12.39 AM IST
- SEC no to clinical trial waiver for Pfizer's Covid pillThe SEC asked the companies to conduct bioavailability and bioequivalence (BA/BE) studies and submit safety data at its meeting on Friday, ...25 Jan, 2022, 05.59 AM IST
- MSN to launch generic anti-COVID pill Molnupiravir under 'Molulow' brandThe group is all set to launch the generic Molnupiravir 200 mg capsules and it is being manufactured at its USFDA and MHRA accredited facil...06 Jan, 2022, 07.01 PM IST
- Domestic pharma companies gear up to launch Merck's Covid pillUnion health minister Mansukh Mandaviya said 13 companies in India will manufacture the drug approved for restricted use under emergency si...29 Dec, 2021, 07.03 AM IST
- Optimus Pharma to launch COVID-19 drug Molnupiravir shortlyThe firm has developed the API (active pharmaceutical ingredient) in house at its R&D centre here. Optimus Pharma has revealed highly promi...28 Dec, 2021, 04.10 PM IST
- Govt panel weighing risks and benefits of Merck's Covid drugThe Subject Expert Committee (SEC) under the drug regulator of India has asked manufacturers in India to specify the category of Covid pati...25 Dec, 2021, 08.14 AM IST
- Panel seeks extra data on Merck's Covid drugThe SEC of the Central Drugs Standard Control Organisation (CDSCO) on Monday reviewed applications from Dr Reddy's, Hetero Labs, Natco Phar...07 Dec, 2021, 03.53 PM IST
- SEC to review companies' applications for Molnupiravir on MondayThe drug is touted as a game-changer in the fight against the pandemic, and a panel of experts of the US Food and Drug Administration (FDA)...04 Dec, 2021, 07.10 AM IST
- Expert panel asks drug cos to submit subgroup data on MolnupiravirMolnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of...20 Nov, 2021, 12.04 AM IST
- Expert panel seeks additional info on Merck's Covid-19 drugMolnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of...19 Nov, 2021, 06.55 AM IST
- Local firms gear up to seek licence for Pfizer's Covid drugUS drug giant Pfizer on Tuesday announced a deal with MPP - a UN-backed public health organization - to issue royalty-free voluntary licenc...18 Nov, 2021, 10.39 AM IST
- Panel to meet today to take up applications seeking nod for MolnupiravirThe firms whose applications that will be taken up are Dr Reddy's Laboratories which has filed for approval in a consortium with five other...18 Nov, 2021, 07.15 AM IST
- MSD enters pact with UN-backed MPP to license COVID drug molnupiravir in 105 countries including IndiaUnder the terms of the agreement, MPP will be permitted to further license non-exclusive sub-licences to manufacturers and diversify the ma...27 Oct, 2021, 08.26 PM IST
- Eli Lilly inks pacts for Baricitinib with Sun Pharma, Cipla, Lupin for COVID-19 treatment in IndiaAs the threat of compulsory licence (CL) looms over big pharma in India, companies are rushing in to sign voluntary licensing agreements th...11 May, 2021, 07.47 AM IST
- Indian drug companies start off a price war on experimental Covid-19 drugOver the next few weeks, close to 10 drug companies including Abbott, Lupin, Micro Labs, Mcleods Pharma, Cipla, Strides Pharma and Dr Reddy...25 Jul, 2020, 07.49 AM IST
- Local Covid drug makers ramp up capacityThis follows companies successfully developing the formulations Favipiravir and Remdesivir, the drugs, which along with dexamethasone have ...23 Jun, 2020, 09.17 PM IST
Load More
